antineoplaston A10
Term · Oncology and biomedicine · MLC-T-ONC-010923
A piperidinedione antineoplaston with potential antineoplastic activity. Antineoplaston A10 was originally isolated from human urine but is now synthetically derived. This agent intercalates into DNA, resulting in cell cycle arrest in G1 phase, reduction of mitosis, and decreased protein synthesis. Antineoplaston A10 may also inhibit ras-oncogene expression and activate tumor suppressor gene p53, leading to cell differentiation and apoptosis.
| Identifier | MLC-T-ONC-010923 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | A10 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010923",
"term": "antineoplaston A10",
"field": "Oncology and biomedicine",
"definition": "A piperidinedione antineoplaston with potential antineoplastic activity. Antineoplaston A10 was originally isolated from human urine but is now synthetically derived. This agent intercalates into DNA, resulting in cell cycle arrest in G1 phase, reduction of mitosis, and decreased protein synthesis. Antineoplaston A10 may also inhibit ras-oncogene expression and activate tumor suppressor gene p53, leading to cell differentiation and apoptosis.",
"abbreviation": "A10",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/antineoplaston-a10/"
}
Record 2,050 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.